Тёмный

MERIT Webinar: Lugano and Oncology Imaging Endpoints 

MERIT CRO
Подписаться 404
Просмотров 51 тыс.
50% 1

Lymphoma is one of the most common hematologic malignancies and accounts for approximately 4% of cancer diagnoses in the US. Lymphoma has many subtypes with various factors to consider in response assessment, including medical imaging review. Lugano classification became the main response criteria in 2014, and since there have been several challenges and pitfalls addressed using the criteria. In this webinar, MERIT discusses the fundamentals of Lugano classification, data collection, and recent academia and industry recommendations on challenges of assessment.
3 key questions that are answered:
1. What are the fundamentals of Lugano classification?
2. What data collection elements are needed when reading Lugano classification?
3. What are the challenges and updated recommendations from industry/academia in Lymphoma reading assessments?

Наука

Опубликовано:

 

15 мар 2023

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 1   
@user-zf2wf9ef5s
@user-zf2wf9ef5s Год назад
42:40 what I have been wondered. I found the answer in there😂
Далее
MERIT Webinar: RECIST 1.1 & Oncology Trial Endpoints
43:39
Looks realistic #tiktok
00:22
Просмотров 6 млн
아이스크림으로 체감되는 요즘 물가
00:16
Envy recreating this new trend ✨ #shorts
00:14
Просмотров 1,9 млн
Non-Hodgkin Lymphoma - What you need to know
10:58
Просмотров 309 тыс.
What is Nuclear Medicine and Molecular Imaging?
46:42
Introduction to CT Chest - Anatomy and Approach
36:54
Просмотров 299 тыс.
PET  CT imaging lymphoma
29:55
Просмотров 13 тыс.
Lecture 1 - Introduction to Radiation Oncology
1:22:06
Просмотров 129 тыс.
How I Approach Upfront and Relapsed DLBCL
21:37
Просмотров 3,6 тыс.
ПОКУПКА ТЕЛЕФОНА С АВИТО?🤭
1:00
OZON РАЗБИЛИ 3 КОМПЬЮТЕРА
0:57
Просмотров 39 тыс.